Condition

Idiopathic Inflammatory Myopathy (IIM) clinical trials and research

• 7Clinical trials
• 4Countries

Newest Idiopathic Inflammatory Myopathy (IIM) clinical trials

All recruiting trials (7)

• OM336 in seropositive autoimmune diseases

  A first-in-human study testing OM336 to see if it is safe and tolerable in adults with seropositive autoimmune diseases, given as subcutaneous injections in increasing doses.

  Recruiting Phase 1 Lakefront Biotherapeutics West LLC · Hamilton, Waikato Region · NCT07229144

• Personalized lab test to predict the best treatment for rheumatic diseases

  This project tests a lab-based cell assay to see if it can predict which DMARD will work best for adults with autoimmune rheumatic diseases such as RA, PsA, axSpA, and GCA.

  Recruiting University of Bonn · Bonn, North Rhine-Westphalia · NCT07150000

• GC012F CAR-T therapy for refractory idiopathic inflammatory myopathy

  This trial will test GC012F, a CAR-T cell therapy, in adults with idiopathic inflammatory myopathy that has not improved with standard treatments.

  Recruiting Early Phase 1 Tongji Hospital · Wuhan, Hubei · NCT07086404

• HBI0101 CAR-T for refractory B‑cell autoimmune rheumatic diseases

  This will test a single infusion of HBI0101 CAR‑T cells in adults with severe, treatment‑resistant B‑cell autoimmune diseases such as SLE, systemic sclerosis, idiopathic inflammatory myopathy, rheumatoid arthritis, or primary progressive MS.

  Recruiting Phase 1 Hadassah Medical Organization · Jerusalem · NCT07085676

• Evaluating OL-108 for autoimmune diseases that have not responded to previous treatments

  This study is testing a new treatment called OL-108 to see if it can help people with autoimmune diseases that haven't improved with other therapies.

  Recruiting at 2 sites Phase 1 Beijing GoBroad Hospital · Beijing and 1 other locations · NCT06980597

• Safety evaluation of CC312 in patients with autoimmune diseases

  This study is testing a new treatment called CC312 to see if it's safe and tolerable for adults with autoimmune diseases like lupus and rheumatoid arthritis.

  Recruiting Early Phase 1 CytoCares Inc · Tianjin, China · NCT06888960

• Using engineered immune cells to treat difficult autoimmune diseases

  This study is testing if a new type of immune cell treatment can help people with tough autoimmune diseases that haven't responded to other therapies.

  Recruiting Second Affiliated Hospital, Zhejiang University, School of Medicine · Hangzhou, Zhejiang · NCT06614270

Related topics

Quick answers

How many Idiopathic Inflammatory Myopathy (IIM) clinical trials are recruiting right now?

7, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 4 countries. The most sites are in China (4 trials), Germany (1 trial), Israel (1 trial), New Zealand (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 1: 3, Early Phase 1: 2. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →